Biotech

All Articles

CAMP 4 is most recent to eye IPO, while Upstream point out $182M program

.RNA biotech CAMP4 Therapeutics has marked out think about a $67 million IPO, with inflammation-focu...

Galecto purchases leukemia medication, loses bone tissue cancer cells asset in pivot

.A year after the failure of an idiopathic lung fibrosis candidate delivered Galecto on a search for...

Judo tosses down $100M to knock senseless kidney health condition

.Taking the mat is Judo Biography, an ambitious biotech equipped with $100 thousand to develop oligo...

AstraZeneca spends CSPC $100M for preclinical heart problem medication

.AstraZeneca has settled CSPC Drug Group $one hundred thousand for a preclinical heart disease medic...

Zephyrm seeks Hong Kong IPO to cash stage 3 tissue therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, declaring (PDF) for an IPO to s...

Frazier Life Sciences collects $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has sourced an even more $630 million for its own fund concentrated on ...

GigaGen gathers around $135M BARDA bucks to beat botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own techn...

GPCR organization Septerna files for IPO on stamina of preclinical information

.Septerna is about to find out exactly how a biotech without "any type of meaningful scientific info...

Kurma finalizes first $154M payload for biggest biotech fund as yet

.European VC agency Kurma Partners has actually introduced its most recent biotech fund, with 140 th...

Prothena advertises one exec while another leaves behind-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and ...